An analysis of the Australian Therapeutic Goods Administration Database of Adverse Event Notifications of diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors in surgical patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: SAGE Publications Country of Publication: United States NLM ID: 0342017 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0310-057X (Print) Linking ISSN: 0310057X NLM ISO Abbreviation: Anaesth Intensive Care Subsets: MEDLINE
    • Publication Information:
      Publication: 2019- : [Thousand Oaks, CA] : SAGE Publications
      Original Publication: Sydney : Australasian Medical Pub. Co.
    • Subject Terms:
      Diabetes Mellitus, Type 2* ; Diabetic Ketoacidosis* ; Sodium-Glucose Transporter 2 Inhibitors*/adverse effects; Australia ; Humans ; Hypoglycemic Agents ; Professionalism
    • Accession Number:
      0 (Hypoglycemic Agents)
      0 (Sodium-Glucose Transporter 2 Inhibitors)
    • Publication Date:
      Date Created: 20200121 Date Completed: 20200303 Latest Revision: 20200303
    • Publication Date:
      20221213
    • Accession Number:
      10.1177/0310057X19892988
    • Accession Number:
      31955586